Cannabinoids


California Cannabis Industry to Hit $6 Billion by 2025

November 16th, 2020 - Ryan Allway

California’s cannabis industry is on track to surpass $6 billion in 2025, according to BDS Analytics, which would represent a sixth of legal cannabis sales in the United States. Although Nevada and a handful of other states experienced COVID-19-related disruptions, California’s mature market has managed to weather the pandemic thus far. Let’s take a closer […]

Christina Lake Cannabis: Disrupting the Market with Ultra-Low Cost Production

September 17th, 2020 - Ryan Allway

Cannabis is quickly moving from a hot commodity to a regular commodity as a growing number of licensed producers put pressure on prices. While the government hopes that falling prices push out black market competition, many companies have seen their margins contract after just a short time in production—spelling danger for investors in the space. […]

How to Invest in a Global Cannabis Portfolio

May 20th, 2020 - Ryan Allway

North America’s cannabis industry may capture the most headlines, but there are many cannabis frontier markets to keep in mind. In fact, North America represented just 25%, or $86 billion, of the $344 billion global cannabis market in 2018, according to New Frontier Data. Asia, Europe, Africa, Latin America, Oceana and the Caribbean are all […]

Led By An Expert Team In The Beverage Industry- Innoviom Is Adapting and Driving Their Business Despite The Current Pandemic

April 16th, 2020 - Ryan Allway

  The COVID-19 outbreak has severely disrupted the economy and could push the world into the sharpest economic contraction since the Great Depression in the 1930s. While the cannabis industry has been largely spared thus far, companies have been forced to adopt new business models and strategies to succeed in the ‘new normal’. Innoviom, a […]

Coping With Stress During the COVID-19 Outbreak with CBD & Adaptogens

April 2nd, 2020 - Ryan Allway

The COVID-19 outbreak has become a major source of stress over the past several weeks. In addition to the fear and anxiety of disease, quarantines and “stay at home” orders have contributed to stress levels, leading to poor sleep, unhealthy eating, and other side-effects. It’s important for everyone to take inventory of their health and […]

Israel Begins Cannabis Exports to Meet Unmet Medical Needs

March 30th, 2020 - Ryan Allway

Israel has long been an international center for cannabis research. THC, the psychoactive ingredient in cannabis, and CBD, the plant’s predominant non-psychoactive ingredient, were first isolated and defined by Israeli researcher Dr. Raphael Mechoulam in the early 1960s. Research continued there in the following decades, and the Israeli government has contributed greatly to the country’s […]

How Cannabis Companies Are Adapting to the ‘New Normal’

March 3rd, 2020 - Ryan Allway

The cannabis industry has shifted its focus from expansion to profitability over the past year. Rather than spending a lot of money to expand into every market, multi-state operators, or MSOs, are starting to pare down their assets and restructure their operations to adapt to the ‘new normal’ — mature markets where profits are king. […]

General Cannabis’ SevenFive Farms Acquisition Provides In-Roads to Colorado

February 7th, 2020 - Ryan Allway

Colorado cannabis sales hit $1 billion in total cannabis-related revenue in 2019, becoming the first state in the country to hit that milestone five years after legalization. In addition, Colorado has the highest per-person spending on cannabis at $280 per year, which is significantly higher than the $220 and $130 annual spend in Washington State […]

Why ‘Second-Mover Advantage’ is Key to Cannabis 3.0

January 26th, 2020 - Ryan Allway

Legal cannabis has become one of the fastest growing industries in history. In less than a decade, it has grown from zero to upwards of $15 billion in global sales, driven by the liberalization of laws around the world. These growth rates are expected to accelerate as more states and countries legalize medical and adult-use […]

What is the Next Stage of Cannabis Investing?

January 13th, 2020 - Ryan Allway

Remember when investments in cannabis and Bitcoin were seen as interchangeable pursuits of the next sky-high return based on a story that sounded plausible, if not downright enticing? In the early days, cannabis investors chased Canadian operators focused on ramping up production to meet the growing demand of a newly legalized Canadian recreation market and, […]

Investors Opening Eyes to Opportunity in Israel Cannabis, Including Exclusive CEO Video Interview Part #2

December 23rd, 2019 - Ryan Allway

There is no country on Earth that has a history steeped in cannabis research like that of Israel. Furthermore, there is no government that is more supportive of medical marijuana research than Israel. Yet, the small country has by and large gone overlooked for what it has to offer as an investment opportunity. That is […]

Isracann Closer to Greenhouse Construction as Israel Cannabis Market Heats Up

December 10th, 2019 - Ash Stringer

Israel has long been recognized for its pioneering contributions to research in the medical cannabis field. Recently, the state made its commitment clear to develop the sector by issuing a white paper on the opportunity to invest in Israeli cannabis. That was followed by the largest medical-marijuana merger ever in the country, with Cannbit Pharmaceuticals […]

Canibrands Capitalizes on CBD with Deep Product Line & Celebrity Support

December 6th, 2019 - Ryan Allway
CaniBrands products

Cannabidiol, better known as CBD, has become one of the most popular wellness products in the United States over the past couple of years. BDS Analytics and Arcview Market Research expect CBD sales to grow at a 49% compound annual growth rate to surpass $20 billion by 2024—making up about half of the total cannabinoid […]

The Supreme Cannabis Company Launches New CBD Product as New Senior Executives Join the Team

December 4th, 2019 - Ash Stringer

2019 has been tough sledding for essentially every public company in the cannabis space. It’s not unlike other times over the last decade when high growth stocks, as they’re colloquially called, have followed large gains with sharp retractions. While unpleasant for market bulls, it is a normal and healthy part of a cycle, particularly for […]

Israel Writing Playbook to Become Cannabis Gateway to Europe

November 21st, 2019 - Ash Stringer

With unprecedented expertise in cannabis research and perfect weather conditions for cultivation, it only makes sense that Israeli lawmakers took a global leadership position in January 2019 by green-lighting the export of medical cannabis to countries where it is allowed. Then it just became a matter of establishing the framework to become one of only […]

Study: Investors Bullish on Future of Cannabis Industry

November 5th, 2019 - Ryan Allway

    CFN Media (OTCQB: CNFN), the leading agency and financial media network dedicated to the North American cannabis industry announces the publication of an article discussing a groundbreaking cannabis investor sentiment study. There’s no doubt 2019 has been tough on many cannabis-related stocks. Perhaps this has been owing to out-of-touch expectations by analysts or […]

CFN Media Exclusive Update from FluroTech President and CEO

November 4th, 2019 - Rachelle Gordon

In the burgeoning cannabis industry, testing companies are often considered the gatekeepers to success. Between consumer demand and regulatory obligations, marijuana producers are compelled to provide a full analysis of what they’re putting on the market and accurate results are crucial. FluroTech (TSX-V: TEST) (OTCQB: FLURF) is a Canadian-based provider of cannabis and hemp testing […]

RYAH Medtech, Inc. Signs Major Purchase Order with International Pharmaceutical Company

October 29th, 2019 - Ryan Allway

New York, NY, October 29, 2019 – RYAH Medtech, Inc. (“RYAH” or the “Company”), a big data and technology company focused on valuable predictive analysis in the global medical plant intake industry, announced today that it has signed an agreement with an international clinic (the “Clinic”) for one of the world’s largest and most comprehensive […]

Isracann Biosciences Launches Phase One Facility Development Program in Israel

October 28th, 2019 - Ryan Allway

Company aims to develop top regional cannabis brands for entry into EU marketplace VANCOUVER, British Columbia, Oct. 28, 2019 (GLOBE NEWSWIRE) — Isracann Biosciences Inc.  (CSE: IPOT) formerly Atlas Blockchain Group Inc. (CSE: AKE) (XFRA: A2PT0E) (OTC: ATLED) (the “Company”) is pleased to provide an operative overview and update regarding facility development activities in Israel. Concurrent to […]

Isracann Biosciences Announces Listing on the CSE and Investor Relations Agreements

October 17th, 2019 - Ryan Allway

VANCOUVER, British Columbia, Oct. 16, 2019 (GLOBE NEWSWIRE) — Isracann Biosciences Inc.  (CSE: IPOT) formerly Atlas Blockchain Group Inc. (CSE: AKE) (XFRA: A49) (OTCPINK: ATLEF) (the “Company”) is pleased to announce the fulfillment of all conditions of its reverse takeover transaction and that the Company has met all conditions to list on the Canadian Securities […]

What if Employers had a Convenient Way to Test for Cannabis Use?

October 11th, 2019 - Robin Lefferts

  With cannabis legalization sweeping across North America after decades of prohibition, there are some natural concerns surrounding the introduction of the drug to the legal marketplace. In the area of safety, most of the questions have surrounded the issue of impaired driving. One topic that hasn’t gotten a lot of press is that of […]

Priming for Expansion, GreenStar Strikes a Deal with Progressive Herbs

October 10th, 2019 - Ryan Allway

GreenStar Biosciences Corp. (CSE: GSTR) already had a strong cannabis market presence through its stake in Cowlitz County Cannabis Cultivation, a leading player in Washington State. Primed for expansion, GreenStar has struck a deal with Progressive Herbs Inc., forging a new joint venture that should make all involved even stronger. Cowlitz County Cannabis is a […]

THC BioMed Planning for New Product Launches

October 9th, 2019 - Ash Stringer

THC BioMed Intl Ltd. (“THC BioMed”) has submitted a new product application for its Pure Cannabis Sticks and is developing a cannabis beverage called “THC Kiss.” Both products are subject to Health Canada approval. The Government of Canada has announced that the production and sale of cannabis edibles, extracts and topicals will be legalized on […]

From Cannabis to Logistics Solutions, ManifestSeven Delivers

September 18th, 2019 - Ryan Allway

Before California legalized medical marijuana in 1996, all cannabis was shuttled around clandestinely in pockets and backpacks between suppliers and users. Even with medical marijuana permitted, the industry was still the Wild West, with limited oversight and growers still acting as the supplier to end users. But, with the legalization of recreational marijuana in California […]

cbdMD Sales Growing, Key Influencers Continue to Bring the Product Mainstream

September 17th, 2019 - Ryan Allway

  CBD, or cannabidiol, has moved into the mainstream, a normalization process that has been supported by several regulatory and legislative events. The framework may be on the government side, but consumer uptake is being accelerated by key influencers promoting brands while educating the public on these events, as well as the potential benefits of […]

CBD Playing an Increasing Role in Health & Wellness

September 17th, 2019 - Tony Deyes

The legalization of cannabis has enabled far greater research into the potential medicinal benefits offered by the plant – especially cannabidiol (CBD), the most abundant non-psychoactive cannabinoid found in both cannabis and hemp. This increased research has led to the creation of hundreds of new and innovative alternatives to health and wellness products.  Rapidly Changing […]

A Leader In Washington, GreenStar Eyes Expansion

September 10th, 2019 - Ash Stringer

Washington State has long been a pioneer in the cannabis industry. Medical marijuana has been legal since 1998 and the state was the first in the U.S. to approve recreational marijuana, doing so on December 6, 2012. The market continues to grow, including retail sales reaching $972 million in 2018 from $851 million in 2017. […]

Sweet Citrus Spice! Supreme Cannabis’ 7ACRES Launches New Sativa Cultivar

September 10th, 2019 - Ash Stringer

In recent years, consumers growing tired of bland beer with low-quality ingredients undergirded a craft beer movement that is still gaining steam. In fact, while overall beer volume sales dipped in 2018, craft beer sales increased 4% by volume and 7% by dollar sales, climbing to 24% of the $114.2 billion U.S. beer market. The point […]

A Look Under the Rug at the Savvy Penetration of Europe’s Cannabis Market by Supreme Heights

September 6th, 2019 - Ryan Allway

As the nascent European legal cannabis market emerges, Canadian companies that have cut their teeth in their home markets are taking that experience overseas to capitalize on a much larger market opportunity. The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) is a model of how to build a successful cannabis portfolio at a blistering […]

Want a Powerplay Cannabis Brand? Know Your Consumer

September 6th, 2019 - Ash Stringer

With recreational or medical marijuana allowed in 33 U.S. states, about 224 million people now have legal access to cannabis. An April Hill-HarrisX poll showed that 84% of Americans now support legalizing marijuana, including 42% of respondents expressing their belief it should be legal for any use. The growing approval rates for cannabis signal a […]


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading